In January 2025, The United Animal Healthcare (Inner Mongolia) Co., Ltd. received official approval for two Class II New Veterinary Drug Certificates for 「Cefovecin Sodium」 and 「Cefovecin Sodium for Injection」. This new veterinary drug is a semi-synthetic, third-generation cephalosporin with broad-spectrum antibacterial activity against Gram-negative bacteria. It also exhibits enhanced resistance to β-lactamases. It is used to treat skin infections caused by susceptible strains of staphylococci and streptococci and urinary tract infections caused by Escherichia coli and/or Proteus spp for dogs; as well as skin infections caused by susceptible strains of Pasteurella multocida and staphylococci and urinary tract infections caused by E. coli for cats.